ESR1 and non-small cell lung carcinoma: Similar effects have been observed in non-small cell lung cancer (NSCLC), where increased ERα and PR gene expression correlates with reduced infiltration of CD4+ and CD8+ cytotoxic T lymphocytes (CTLs) 56, 57.